Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Sig Transduct Target Ther 4, 29 (2019)
Sixty participants who are cognitively normal or have MCI or mild AD dementia, and shown to be amyloid positive on amyloid PET or with CSF AD biomarkers, will be studied for 8 weeks
The false economy of using degraded medication rarely saves money in the aggregate
Evaluate regulatory evidence, quality systems, analytical capability, change control and supply continuity before using price or lead time to choose a source
US$ 21.24
US$ 20.12
US$ 27.56
US$ 26.35
US$ 29.29
US$ 22.89
US$ 22.41
